Where did you get that information? From the information below it appears it is still run by Zioharm under the supervision of Dr Arnold Gelb, Executive Director, Clinical Development at Zioharm Oncology.
From the Zioharm's 2+ years old
PR:
In addition to Lurie Children’s, the Phase 1 study will be conducted at Dana-Farber Cancer Institute in Boston and the University of California, San Francisco. It is sponsored by ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a Boston-based biopharmaceutical company focused on developing new gene and cell-based immunotherapies for cancer. Lurie Children’s cancer program is part of Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
From the
CT site:
United States, California |
University of California San Francisco, Benioff Children's Hospital | |
San Francisco, California, United States, 94158 |
United States, Illinois |
Lurie Children's Hospital of Chicago | |
Chicago, Illinois, United States, 60611 |
United States, Massachusetts |
Dana- Farber Cancer Institute | |
Boston, Massachusetts, United States, 02215 |